• Home
• triple q breast
• Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft

Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft

5 (450) · $ 8.00 · In stock

Targeting oncogenic vulnerabilities in triple negative breast

Generation of Low-C maps for DLBCL primary tissue and healthy B-cells.

Molecules, Free Full-Text

Inhibition of CHEK1 and WEE1 re-sensitize carboplatin-resistant

Cancers, Free Full-Text

Chromatin looping at the mammalian globin loci. (a) Genomic

Rewiring of the 3D genome during acquisition of carboplatin

Frontiers 3D cancer models: One step closer to in vitro human

Dynamic 3D chromatin organization in late spermatogenesis a, Schematic

MM2 Values Updated April 2023 , mm2 supreme values

Targeting regulated cell death (RCD) with small-molecule compounds

The role and application of vesicles in triple-negative breast

Anti-MCUB antibody produced in rabbit Prestige Antibodies Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution CCDC109B

PDF) Multi-level 3D genome organization deteriorates during breast cancer progression

Metabolic adaptation towards glycolysis supports resistance to